search
Back to results

Combination Treatment With Green Tea Extract and Statins in Patients With Hypercholesterolemia (GTE-Stat)

Primary Purpose

Hypercholesterolemia

Status
Completed
Phase
Phase 2
Locations
Greece
Study Type
Interventional
Intervention
Green Tea Extract - Catechins
Placebo
Sponsored by
University of Thessaly
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Hypercholesterolemia focused on measuring Green Tea Extract, Catechins, Statin, atorvastatin, body composition, visceral fat, steatosis, oxidative stress, quality of life, OGTT, OGIS, ISI matsuda

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Total cholesterol >200mg/dl, or LDL >160 mg/dl

Exclusion Criteria:

  • normal lipidemic profile, on statin medication, diabetes mellitus, liver disease, severe hypertension, pregnancy, or severe side effects after 4 weeks of treatment

Sites / Locations

  • General Hospital of Trikala

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

GTE

CON

Arm Description

The experimental group will receive 20 mg atorvastatin (Lipitor) daily and 600 mg. of pure catechin in capsules

The control group will receive 20 mg atorvastatin (Lipitor) and Placebo in identical capsules containing 600 mg placebo for 12 weeks

Outcomes

Primary Outcome Measures

Reduction in Total CHO and LDH

Secondary Outcome Measures

lipids profile, body composition, visceral adiposity, Redox status, glucose disposal, Insulin sensitivity index, liver fat infiltration, quality of life parameters

Full Information

First Posted
July 21, 2009
Last Updated
December 2, 2010
Sponsor
University of Thessaly
Collaborators
Greek Ministry of Development, General Hospital of Trikala, Dept of Internal Medicine, University General Hospital of Larissa, Dept of Medicine
search

1. Study Identification

Unique Protocol Identification Number
NCT00944827
Brief Title
Combination Treatment With Green Tea Extract and Statins in Patients With Hypercholesterolemia
Acronym
GTE-Stat
Official Title
The Effects of Catechin Supplementation (Green Tea Extract), in Combination With the Classic Treatment for the Reduction of Hypercholesterolemia (Statin Therapy) on the Treatment's Effectiveness and in the Reduction of Classic Side Effects.
Study Type
Interventional

2. Study Status

Record Verification Date
July 2009
Overall Recruitment Status
Completed
Study Start Date
September 2007 (undefined)
Primary Completion Date
October 2009 (Actual)
Study Completion Date
October 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University of Thessaly
Collaborators
Greek Ministry of Development, General Hospital of Trikala, Dept of Internal Medicine, University General Hospital of Larissa, Dept of Medicine

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
There is a positive correlation between serum's cholesterol levels and death from cardiovascular disease, especially coronary artery disease. The reduction of plasma lipids levels is one of the main goals of prevention. Research has shown that green tea has beneficial effects on health due to the polyphenolic substances (catechins) that it contains. Studies have shown that prolonged consumption of polyphenols has a positive effect on factors related to cardiovascular risk such as obesity, dislipidemia and various indicators of oxidative stress. The aim of this study was to examine the possible effects of catechin supplementation, in combination with the classic treatment for the reduction of hypercholesterolemia, statin therapy, on the treatment's effectiveness and in the reduction of classic side effects.
Detailed Description
This is a randomized, double - blind placebo controlled trial. The patients will be divided randomly in two groups; one group will receive statin and catechin, while the other statin and placebo for 12 weeks. The experimental group will receive 20 mg atorvastatin (Lipitor) daily and 600 mg of catechin in capsules, while the control group will receive 20 mg atorvastatin (Lipitor) and Placebo in identical capsules of 600 mg for the same time period. The patients will undergo biochemical evaluation in which the serum lipids, the levels of oxidative stress and the antioxidant capacity will be assessed. Body composition will be calculated with anthropometric measurements, while the levels of visceral fat, the subcutaneous fat, as well as the level of liver fat infiltration will be examined with the use of computed tomography images. Factors related to the patients' quality of life will be assessed by a series of questionnaires. The investigators hypothesized that the combination treatment with statin and green tea extract (catechins)will improve in a greater extent the lipidemic profile, increase antioxidant capacity, reducing significantly visceral fat and intrahepatic lipids content.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypercholesterolemia
Keywords
Green Tea Extract, Catechins, Statin, atorvastatin, body composition, visceral fat, steatosis, oxidative stress, quality of life, OGTT, OGIS, ISI matsuda

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
GTE
Arm Type
Experimental
Arm Description
The experimental group will receive 20 mg atorvastatin (Lipitor) daily and 600 mg. of pure catechin in capsules
Arm Title
CON
Arm Type
Placebo Comparator
Arm Description
The control group will receive 20 mg atorvastatin (Lipitor) and Placebo in identical capsules containing 600 mg placebo for 12 weeks
Intervention Type
Dietary Supplement
Intervention Name(s)
Green Tea Extract - Catechins
Intervention Description
Combination treatment with 20 mg atorvastatin and 600mg green tea extract, daily for 12 weeks
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
Combination treatment with 20 mg atorvastatin and 600mg placebo, daily for 12 weeks
Primary Outcome Measure Information:
Title
Reduction in Total CHO and LDH
Time Frame
12 wks
Secondary Outcome Measure Information:
Title
lipids profile, body composition, visceral adiposity, Redox status, glucose disposal, Insulin sensitivity index, liver fat infiltration, quality of life parameters
Time Frame
12 wks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Total cholesterol >200mg/dl, or LDL >160 mg/dl Exclusion Criteria: normal lipidemic profile, on statin medication, diabetes mellitus, liver disease, severe hypertension, pregnancy, or severe side effects after 4 weeks of treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Giorgos K Sakkas, PhD
Organizational Affiliation
UTH - CERETETH
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Christina Karatzaferi, PhD
Organizational Affiliation
University of Thessaly
Official's Role
Principal Investigator
Facility Information:
Facility Name
General Hospital of Trikala
City
Trikala
State/Province
Thessaly
ZIP/Postal Code
42100
Country
Greece

12. IPD Sharing Statement

Learn more about this trial

Combination Treatment With Green Tea Extract and Statins in Patients With Hypercholesterolemia

We'll reach out to this number within 24 hrs